A recent meta-analysis of 18 studies showed that women with acute ischemic stroke are less likely to receive treatment with intravenous alteplase than men. 1 Because women account for ≥60% of all deaths attributable to stroke, sex differences in treatment of acute stroke are important. 2 There are several hypotheses about this sex disparity. 1 Women are generally older. Although age is not a contraindication for treatment, 3 physicians may be less inclined to treat older patients. Women may more frequently have contraindications for thrombolysis, such as use of oral anticoagulants.
So far, the lower treatment rate in women has not yet been explained. The aim of the present study is to assess the differences between men and women in treatment with intravenous alteplase and to study reasons for this difference.
Methods
We analyzed data from the Promoting Acute Thrombolysis for Ischaemic Stroke (PRACTISE) study; all individuals ≥18 years of age with acute stroke presenting within 24 hours of symptom onset were registered in 12 hospitals in the Netherlands between 2003 and 2005. Patients presenting within 4 hours were assessed in more detail. Stroke severity, assessed with the National Institutes of Health Stroke Scale (NIHSS), was available in all patients with an ischemic stroke presenting within 4 hours.The study protocol and main results have been published elsewhere. 4, 5 We defined outcome as treatment with recombinant tissue plasminogen activator in the total stroke population and in the subgroup of patients with ischemic stroke presenting within 4 hours, and onsetto-door time as the time from onset of symptoms to presentation and registration at the emergency department. We used a multivariable logistic regression model with adjustment for age and expressed associations as adjusted odds ratios with 95% confidence intervals (CIs). We explored the effect of onset-to-door time, intervention of a general practitioner (GP), and contraindications for treatment on the likelihood of being treated.
Results
A total of 5515 patients were included in the PRACTISE study, 2778 (50.4%) women and 2737 men. On average, women were 4 years older than men. The median NIHSS score was 6 in women and 5 in men (Table 1) . Considering the total population, fewer women were treated with intravenous alteplase (11% versus 14%; odds ratio, 0.8; 95% CI, 0.7-0.9).
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Discussion
Our study showed that women are treated just as often with thrombolytic agents as men in the Netherlands, once they arrived in time for treatment. However, if we consider the complete stroke care pathway, fewer women presented at the emergency department within 4 hours of stroke onset. So far, this lower treatment rate in women has not yet been clarified. 1 Our results suggest that this difference could be caused by delayed presentation to the emergency department. This is also confirmed in other studies. 6 Also, in myocardial infarction, there is an underutilization of thrombolytic therapy in women and a delay in care seeking. 7 Possible reasons for this delay are differences in presenting symptoms and the older age of women on average. Older people more often live alone 8 and experience an unwitnessed stroke. Living alone makes care seeking difficult and also delays the referral and diagnostic process.
This study has some limitations. Limited demographic details of the included patients were available; therefore, no assumptions on the influence of specific symptoms on onsetto-door time could be made. Also, the data were collected from 2003 to 2005 and therefore can be a little outdated. The strength of the present study is that all patients in the participating centers and the intervention of the GPs were registered and therefore provide a good representation of the whole population. The participating hospitals were representative in size, geographic distribution, and frequency of procedures.
Finally, the impact of sex differences in treatment of acute stroke is huge: ≈25% more women should be treated with alteplase to abolish the difference, and this number is increasing with the aging population. Therefore, further research is needed to understand the reasons why fewer women with acute stroke are admitted in time for treatment to be able to deal with this inequality.
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